Clifton Park Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Clifton Park Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$21.4M	Sell	612,500 -270,391	-31%	-$17.4M	2.43%	8
2015 Q3	$81.2M	Buy	882,891 +55,972	+7%	+$4.84M	7.26%	5
2015 Q2	$72.7M	Hold	826,919	–	–	5.29%	7
2015 Q1	$61.4M	Buy	826,919 +36,364	+5%	+$2.57M	3.74%	9
2014 Q4	$44.3M	Hold	790,555	–	–	2.63%	11
2014 Q3	$35.9M	Hold	790,555	–	–	2.57%	10
2014 Q2	$32.7M	Hold	790,555	–	–	2.1%	12
2014 Q1	$54.8M	Hold	790,555	–	–	3.39%	9
2013 Q4	$47.6M	Hold	790,555	–	–	2.75%	14
2013 Q3	$48.1M	Sell	790,555 -134,445	-15%	-$9.53M	2.85%	15
2013 Q2	$62M	Buy	+925,000	New	+$41.6M	3.68%	9

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clifton Park Capital Management's CLVS Position: Q4 2015 in Review

Clifton Park Capital Management reduced its Clovis Oncology, Inc. (CLVS) stake by 31% in Q4 2015, selling an estimated $17.4M and leaving 612,500 shares worth $21.4M. The position accounts for 2.43% of the portfolio, ranked #8.

Clifton Park Capital Management first reported a position in CLVS in Q2 2013 and has held it in 11 quarters since. The position peaked at $81.2M in Q3 2015. 157 funds tracked by Wall St. Rank hold CLVS as of Q4 2015.

Clifton Park Capital Management held 612,500 shares of Clovis Oncology, Inc. worth $21.4M as of Q4 2015.
Clifton Park Capital Management sold 270,391 Clovis Oncology, Inc. shares in Q4 2015, an estimated $17.4M.
Clovis Oncology, Inc. made up 2.43% of Clifton Park Capital Management's portfolio in Q4 2015, its #8 holding.
Clifton Park Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and has held it in 11 quarters since.
Clifton Park Capital Management's Clovis Oncology, Inc. position peaked at $81.2M in Q3 2015.
157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2015.

Based on Clifton Park Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.